Provided by Tiger Trade Technology Pte. Ltd.

LivaNova PLC

78.26
-0.4800-0.61%
Pre-market: 79.160.9007+1.15%04:14 EDT
Volume:823.21K
Turnover:64.62M
Market Cap:4.30B
PE:23.09
High:80.00
Open:78.65
Low:78.00
Close:78.74
52wk High:85.76
52wk Low:48.82
Shares:54.93M
Float Shares:54.68M
Volume Ratio:1.70
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.39
EPS(LYR):-4.4500
ROE:15.40%
ROA:5.23%
PB:3.24
PE(LYR):-17.59

Loading ...

Press Release: LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

Dow Jones
·
Aug 05

Lotus Property Schedules Public Consultation on Library Street Affordable Housing Plan

Reuters
·
Aug 03

Earning Preview: LivaNova PLC this quarter’s revenue is expected to increase by 14.59%, and institutional views are bullish

Earnings Agent
·
Jul 29

3 Service Sector Stocks With Pricing Power Investors Should Watch

Simply Wall St.
·
Jul 15

LivaNova (LIVN) Joins Russell Indexes, Is The Stock Fully Priced?

Simply Wall St.
·
Jul 04

Analysts’ Opinions Are Mixed on These Healthcare Stocks: LivaNova (LIVN), Gain Therapeutics (GANX) and Tempus AI, Inc. Class A (TEM)

TIPRANKS
·
Jul 02

Livanova Initiated at Hold by Freedom Capital Markets

Dow Jones
·
Jul 01

Livanova Schedules Conference Call on Second-quarter 2026 Results

Reuters
·
Jun 24

Livanova to Announce Second-quarter 2026 Results

THOMSON REUTERS
·
Jun 24

3 Healthcare Stocks For Lower Volatility And Strong Profit Margins

Simply Wall St.
·
Jun 24

LivaNova Is Maintained at Overweight by Keybanc

Dow Jones
·
Jun 22

LivaNova price target raised to $92 from $83 at KeyBanc

TIPRANKS
·
Jun 22

LivaNova (LIVN) Gets a Buy from KeyBanc

TIPRANKS
·
Jun 22

LivaNova Director Francesco Bianchi disposes 1,686 shares worth $134,924.34

Reuters
·
Jun 18

BRIEF-Livanova Demonstrates 84.5% Cumulative Response Rate With Polysync Programming In OSPREY Study

Reuters
·
Jun 17

LivaNova's PolySync Algorithm Supports Improvement in Sleep Apnea Treatment Response Rate

MT Newswires Live
·
Jun 17

LivaNova announces new data on PolySync programming from OSPREY study

TIPRANKS
·
Jun 16

LivaNova says PolySync programming lifts OSPREY sleep apnea response rate to 84.5%

Reuters
·
Jun 16

LivaNova - No Serious Adverse Events Reported With Polysync Programming in Substudy

THOMSON REUTERS
·
Jun 16

LivaNova Demonstrates 84.5% Cumulative Response Rate With Polysync Programming in Osprey Study for Obstructive Sleep Apnea

THOMSON REUTERS
·
Jun 16